RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.87B
AUM Growth
+$330M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$52.9M
2
+$48.7M
3
+$36.4M
4
TGTX icon
TG Therapeutics
TGTX
+$21.9M
5
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$19M

Top Sells

1
+$56.4M
2
+$16.3M
3
+$11.4M
4
SPRO icon
Spero Therapeutics
SPRO
+$10.9M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$1.74M

Sector Composition

1 Healthcare 93.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.61M 0.14%
33,437
27
– –
-101,667
28
– –
-741,647
29
– –
-40,000
30
– –
-506,276
1
2